ID Biomedical (IDB-T) Stock Predictions - Stockchase
WATCH LIST
19
ID Biomedical (IDB-T)

ON STOCKCHASE SINCE Oct 2000

gene technology & vaccines

biotechnology/pharmaceutical

ID Biomedical

IDB-T

0 watching          
Join the Discussion

ID Biomedical (IDB-T) SAVE Dec, 31, 1969, 7:00 pm

0.00 0 (100%)

This company is not ACTIVE.

What the experts are saying about IDB-T



  • All
  • Filtered
Signal Opinion Expert
HOLD
ID Biomedical(IDB-T) 

September 20, 2005

GlaxcoSmithKline (GSK-N) is taking the company over. Speculation is that someone else will come in with a better offer. Can't see much risk in holding on to your shares.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
GlaxcoSmithKline (GSK-N) is taking the company over. Speculation is that someone else will come in with a better offer. Can't see much risk in holding on to your shares.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Norman Levine

Managing D, Portfolio Management...

Price Price
$34.900
Owned Owned
Unknown

BUY
ID Biomedical(IDB-T) 

May 9, 2005

Have a large vaccine contract in the US. Should have a large increase in earnings and the stock should have a lot of upside.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Have a large vaccine contract in the US. Should have a large increase in earnings and the stock should have a lot of upside.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Jean-Francois T

Senior Por, Sprott Asset Managem...

Price Price
$21.500
Owned Owned
Yes

DON'T BUY
ID Biomedical(IDB-T) 

December 3, 2004

Biotech stocks are very risky. This one has done very well on the flu vaccine problem in the US. A low margin business. Very expensive.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Biotech stocks are very risky. This one has done very well on the flu vaccine problem in the US. A low margin business. Very expensive.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Jean-Francois T

Senior Por, Sprott Asset Managem...

Price Price
$20.050
Owned Owned
No

BUY
ID Biomedical(IDB-T) 

August 23, 2004

The pharmaceutical sector has been torn apart. This company that has done a very good job in managing and developing some products.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
The pharmaceutical sector has been torn apart. This company that has done a very good job in managing and developing some products.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Robert Floyd

President, R A Floyd Management...

Price Price
$14.640
Owned Owned
Yes

BUY on WEAKNESS
ID Biomedical(IDB-T) 

September 22, 2003

Likes the story. Has had a pretty good run, but has more room to go. Very strong news out of the company. Some trial results still to come out in the next little while.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Likes the story. Has had a pretty good run, but has more room to go. Very strong news out of the company. Some trial results still to come out in the next little while.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Robert Floyd

President, R A Floyd Management...

Price Price
$25.470
Owned Owned
Unknown

BUY on WEAKNESS
ID Biomedical(IDB-T) 

July 29, 2003

Developing a flu vaccine. Well cashed up. Would buy it, but at a lower level.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Developing a flu vaccine. Well cashed up. Would buy it, but at a lower level.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$17.540
Owned Owned
No

BUY
ID Biomedical(IDB-T) 

March 3, 2003

Good product. In final phases of testing.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Good product. In final phases of testing.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Robert Floyd

President, R A Floyd Management...

Price Price
$8.160
Owned Owned
Unknown

WEAK BUY
ID Biomedical(IDB-T) 

February 4, 2003

Very volatile. Well managed and has a lot of cash.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Very volatile. Well managed and has a lot of cash.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$10.060
Owned Owned
Unknown

BUY
ID Biomedical(IDB-T) 

January 15, 2003

Still has substantial upside. Into some interesting products.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Still has substantial upside. Into some interesting products.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Robert Floyd

President, R A Floyd Management...

Price Price
$11.450
Owned Owned
Unknown

PAST TOP PICK
ID Biomedical(IDB-T) 

April 5, 2002

(Was a top pick on Dec 21 up 50%) Can still go higher.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(Was a top pick on Dec 21 up 50%) Can still go higher.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Robert Floyd

President, R A Floyd Management...

Price Price
$9.610
Owned Owned
Unknown

TOP PICK
ID Biomedical(IDB-T) 

December 21, 2001

Well capitalized. Strong management.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Well capitalized. Strong management.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Robert Floyd

President, R A Floyd Management...

Price Price
$6.640
Owned Owned
Unknown

TOP PICK
ID Biomedical(IDB-T) 

July 9, 2001

biotechnology/pharmaceutical
0 0 0 0 0
0 comments
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Robert Floyd

President, R A Floyd Management...

Price Price
$5.150
Owned Owned
Unknown

TOP PICK
ID Biomedical(IDB-T) 

June 14, 2001

Strong cash position. Good mngmnt. Good outlook.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Strong cash position. Good mngmnt. Good outlook.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Robert Floyd

President, R A Floyd Management...

Price Price
$6.400
Owned Owned
Unknown

TOP PICK
ID Biomedical(IDB-T) 

May 14, 2001

Well capitalized. Good product line.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Well capitalized. Good product line.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Robert Floyd

President, R A Floyd Management...

Price Price
$5.950
Owned Owned
Unknown

TOP PICK
ID Biomedical(IDB-T) 

March 28, 2001

New acquisition is a good fit. Strong cash positions.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
New acquisition is a good fit. Strong cash positions.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Robert Floyd

President, R A Floyd Management...

Price Price
$4.810
Owned Owned
Unknown

Showing 1 to 15 of 19 entries
Successfully Saved Company
Successfully Saved Company
4+
JOIN THE DISCUSSION
4 comments in the last 7 days